Circulation, Vol 81, 1849-1859, Copyright © 1990 by American Heart Association
KR Karsch, KK Haase, W Voelker, A Baumbach, M Mauser and L Seipel
A clinical study was conducted to evaluate the efficacy and safety of
percutaneous coronary excimer laser angioplasty in 60 patients with
coronary artery disease. Forty-nine patients had stable exertional angina,
and 11 patients had unstable angina despite medical therapy. A novel 1.4-mm
diameter catheter with 20 quartz fibers of 100-microns diameter each
arranged concentrically around a central lumen suitable for a 0.014-in.
flexible guide wire was coupled to an excimer laser. A commercial excimer
laser emitting energy at a wavelength of 308 nm with a pulse duration of 60
nsec was used. The laser was operated at 20 Hz. Mean energy transmission
was 30 +/- 5 mJ/mm2. In five of the 60 patients, laser angioplasty was not
attempted. In 23 patients with laser ablation alone, percent stenosis
decreased from 76 +/- 14% before to 27 +/- 17% after ablation and was 34
+/- 15% at the early follow-up angiogram. In 32 patients, additional
balloon angioplasty was performed because of vessel closure after laser
ablation in 11 and an insufficient qualitative result in 21 patients. Of
the 11 patients with unstable angina, one patient died due to vessel
closure 3 hours after intervention, and two patients developed a myocardial
infarction. In 22 of 47 patients with late follow-up angiography,
restenosis within the 6- month follow-up period occurred. Rate of
restenosis was higher in patients treated with laser ablation and balloon
angioplasty (16 of 28) than in patients treated with laser ablation alone
(six of 19). These results suggest that coronary excimer laser angioplasty
for ablation of obstructive lesions is feasible and safe in patients with
stable angina. However, development of new catheter systems is necessary
for an improved success rate.
ARTICLES
Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris. Acute results and incidence of restenosis during 6-month follow-up
Department of Medicine, University Hospital, Tuebingen, FRG.
This article has been cited by other articles:
![]() |
G. Wright, L. Michalis, and P. Rolfe Insularity and professional protectionism or matrixing and professional security in the provision of perfusion services Perfusion, March 1, 1995; 10(2): 89 - 92. [PDF] |
||||
![]() |
L Corr Fortnightly Review: New methods of making blocked coronary arteries patent again BMJ, September 3, 1994; 309(6954): 579 - 583. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |